141 related articles for article (PubMed ID: 6175933)
1. [Preliminary results of a chemotherapy study of patients with squamous cell carcinoma in the head and neck region. Comparison of 2 therapeutic regimens: cis-diamminodichloroplatinum (II) and bleomycin compared to methotrexate and vindesine].
von Heyden HW; Beyer JH; Matthaei A; Nagel GA; Schröder M
Onkologie; 1981 Dec; 4(6):296-9. PubMed ID: 6175933
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of epidermoid head and neck cancer with cisplatinum/bleomycin vs methotrexate/vindesine].
Schröder M; von Heyden HW; Beyer JH; Klee M
Laryngol Rhinol Otol (Stuttg); 1981 Jun; 60(6):331-3. PubMed ID: 6167831
[TBL] [Abstract][Full Text] [Related]
3. [2d interim evaluation of a chemotherapy study on patients with squamous cell carcinomas of the head-neck area. A comparison of 2 therapy regimens: cis-diamminedichloroplatinum (II) and bleomycin versus methotrexate and vindesine].
Schröder M; von Heyden HW; Scherpe A; Borghardt J; Beyer JH; Nagel GA; Gerhartz H; Kastenbauer E; Westerhausen M; Schroeder M; Caliebe W; Rudert H; Lissers R; Hofmann J; Schneider B
Onkologie; 1983 Jun; 6(3):114-7. PubMed ID: 6193472
[TBL] [Abstract][Full Text] [Related]
4. [Cytostatic therapy of advanced squamous cell carcinoma of the head and neck. A randomized study comparing cis-dichlorodiammineplatinum(II) and bleomycin with methotrexate and vindesine].
von Heyden HW; Schröder M; Scherpe A; Beyer JH; Kaboth U; Stennert E; Nagel GA; Gerhartz H; Foth B; Kastenbauer E
Onkologie; 1984 Jun; 7(3):183-90. PubMed ID: 6205337
[TBL] [Abstract][Full Text] [Related]
5. Phase II study of methotrexate, vinblastine, doxorubicin, and cisplatin in patients with squamous cell carcinoma of the upper respiratory or alimentary passages of the head and neck.
Okuno SH; Mailliard JA; Suman VJ; Edmonson JH; Creagan ET; Nair S; Levitt R; Kugler JW
Cancer; 2002 Apr; 94(8):2224-31. PubMed ID: 12001121
[TBL] [Abstract][Full Text] [Related]
6. [Results of primary chemotherapy in 44 patients with advanced squamous cell carcinoma in the area of the head and neck].
von Heyden HW; Schröder M; Scherpe A; Stennert E; Beyer JH; Nagel GA; Hoffmann H; Schneider B
HNO; 1984 Nov; 32(11):454-9. PubMed ID: 6210278
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy for head and neck cancer. Comparison of cisplatin + vinblastine + bleomycin versus methotrexate.
Williams SD; Velez-Garcia E; Essessee I; Ratkin G; Birch R; Einhorn LH
Cancer; 1986 Jan; 57(1):18-23. PubMed ID: 2416423
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy of squamous head and neck cancer: a prospective randomized trial comparing cis-platinum and bleomycin with methotrexate and vindesine.
von Heyden HW; Schröder M; Scherpe A; Borghardt J; Beyer JH; Nagel GA; Gerhartz H; Foth B; Kastenbauer E; Westerhausen M
Recent Results Cancer Res; 1985; 98():148-52. PubMed ID: 2412266
[No Abstract] [Full Text] [Related]
9. [Chemotherapy of head and neck squamous cell cancer with vindesine (Eldesine) and cis-platinum (Platinex) (author's transl)].
Ruffmann R; Seifert R; Ross H; Sturm E
Laryngol Rhinol Otol (Stuttg); 1982 Jul; 61(7):406-10. PubMed ID: 7202092
[TBL] [Abstract][Full Text] [Related]
10. [Experiences using combination chemotherapy with cis-platinum, bleomycin and methotrexate in the management of advanced squamous cell carcinomas of the head and neck (author's transl)].
Jahnke V
HNO; 1980 Dec; 28(12):405-8. PubMed ID: 6161913
[TBL] [Abstract][Full Text] [Related]
11. Continuous vindesine infusion in advanced head and neck cancer.
Popkin JD; Bromer RH; Vaughan CW; Byrne RE; Licciardello JT; Hoffer SM; Welch JM; Fofonoff SA; Strong MS; Hong WK
Am J Clin Oncol; 1983 Jun; 6(3):301-4. PubMed ID: 6846248
[TBL] [Abstract][Full Text] [Related]
12. Phase-II study of cis-diammine-dichloro platinum (cis-platinum), bleomycin and methotrexate for advanced squamous cell carcinoma of head and neck.
Espana P; Smith F; Abrams J; Haidak D; Ueno W; Woolley P; Schein P
Cancer Chemother Pharmacol; 1984; 12(2):98-100. PubMed ID: 6199132
[TBL] [Abstract][Full Text] [Related]
13. Bleomycin and cis-platinum with or without mitomycin C in 110 previously untreated patients with head and neck cancer.
Israel L; Aguilera J; Soudant J; Penot JC; Breau JL; Morere JF
Am J Clin Oncol; 1983 Jun; 6(3):305-11. PubMed ID: 6189388
[TBL] [Abstract][Full Text] [Related]
14. A randomized trial of the combination of cis-platinum, oncovin and bleomycin (COB) versus methotrexate in patients with advanced squamous cell carcinoma of the head and neck.
Drelichman A; Cummings G; Al-Sarraf M
Cancer; 1983 Aug; 52(3):399-403. PubMed ID: 6190548
[TBL] [Abstract][Full Text] [Related]
15. Second-line chemotherapy with bleomycin, methotrexate, and vinorelbine (BMV) for patients with squamous cell carcinoma of the head, neck and esophagus (SCC-HN&E) pretreated with a cisplatin-containing regimen: a phase II study.
Moroni M; Giannetta L; Gelosa G; Secondino S; Chillura G; Colombo E; Siena S
J Chemother; 2003 Aug; 15(4):394-9. PubMed ID: 12962369
[TBL] [Abstract][Full Text] [Related]
16. Treatment of advanced epidermoid carcinoma of the head and neck using methotrexate, bleomycin and cis-platinum.
Orsini MA; Strauss M; Zaino RJ; Messeih AA; Harvey HA; Lipton A
Trans Pa Acad Ophthalmol Otolaryngol; 1984; 37(1):71-6. PubMed ID: 6204427
[No Abstract] [Full Text] [Related]
17. Combination chemotherapy with cisplatin, bleomycin, and methotrexate in patients with advanced head and neck cancer.
Von Hoff DD; Alberts DS; Mattox DE; Coulthard S; Dana B; Manning M; Myers JW; Griffin CB
Cancer Clin Trials; 1981; 4(2):215-8. PubMed ID: 6166408
[TBL] [Abstract][Full Text] [Related]
18. Randomized comparison of cis-diamminedichloroplatinum versus cis-diamminedichloroplatinum, methotrexate, and bleomycin in recurrent squamous cell carcinoma of the head and neck.
Davis S; Kessler W
Cancer Chemother Pharmacol; 1979; 3(1):57-9. PubMed ID: 93988
[No Abstract] [Full Text] [Related]
19. [Pathohistologic changes after induction cytostatic therapy with methotrexate (M), bleomycin (B) and cisplatin (P)--(MBP)].
Böheim K; Mikuz G; Böheim C
Laryngol Rhinol Otol (Stuttg); 1982 May; 61(5):246-50. PubMed ID: 6178922
[TBL] [Abstract][Full Text] [Related]
20. [Indications for cytostatic therapy of recurrent cancer].
Schröder M; Stennert E; von Heyden HW; Scherpe A
HNO; 1984 Jun; 32(6):245-8. PubMed ID: 6206035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
